CENTRO DE IMAGEM DIAGNOSTICS S.A. (“Company”. “Alliar”) (B3: AALR3) further to the Notice to the Market disclosed on September 22, 2022, hereby informs its shareholders and the market in general that it has been informed by Fonte de Saúde Fundo de Investimento em Participações Multiestratégia, the Company’s controlling shareholder (“Offeror”), that a new version of the draft of the Notice of Public Offering for the Acquisition of Company Shares through Disposal of Control (“Tender Offer”) was filed today, in compliance with the requirements of the Superintendence of Securities Registration – SRE and B3 S.A. – Brasil, Bolsa, Balcão (“B3”), under the Request for Registration of the Tender Offer before the Brazilian Securities and Exchange Commission (“CVM”).
The Offeror clarified that, among the changes made, is the change in the price per share to be paid under the Tender Offer, notably due to the Decision of CVM’s Board, of September 20, 2022, informed to the Offeror and to the Company on September 22, 2022, through Official Letter 495/2022/CVM/SRE/GER-1, and disclosed by the Company on a Notice to the Market on the same date. Consequently, the price per share to be paid by the Offeror in cash under the Tender Offer is now R$20.75937, plus the variation of the SELIC rate from April 14 to the date of the financial settlement of the Tender Offer.
The draft of the Notice is available on the CVM website (https://sistemas.cvm.gov.br/), in the “Ofertas Públicas” tab, on the list on the left side of the page, then in “OPA – Oferta Pública de Aquisição de Ações” > “Em Análise” > “Centro de Imagem Diagnósticos S.A.” > “Edital”.
Finally, the Offeror informed the Company that the request for registration of the Tender Offer is under analysis by the CVM, and this Notice to the Market is exclusively for information purposes and not an offer for the acquisition of securities.
São Paulo, October 06, 2022.
To access the full document, click here.
Pedro Thompson
CEO & IRO
E-mail: ri@alliar.com